Skip to content
healthcare.dev

Loratadine and Pseudoephedrine

NDC 0363-0725, Loratadine and Pseudoephedrine, tablet, film coated, extended release, from Walgreen Company.

Product NDC
0363-0725
Status
Listed
Labeler
Walgreen Company
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA076557
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0363-0725 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LORATADINE10 mg/1
  • PSEUDOEPHEDRINE SULFATE240 mg/1

Pharmacologic classes

Adrenergic alpha-Agonists [MoA]; alpha-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
0363-0725-15003630725151 BLISTER PACK in 1 CARTON (0363-0725-15) / 15 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
0363-0725-56003630725561 BLISTER PACK in 1 CARTON (0363-0725-56) / 5 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
0363-0725-69003630725691 BLISTER PACK in 1 CARTON (0363-0725-69) / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 0363-0725 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0363-0725 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0363-0725. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.